Surgical management of melanoma
- PMID: 24880941
- DOI: 10.1016/j.hoc.2014.02.009
Surgical management of melanoma
Abstract
Surgery remains the mainstay of treatment of every patient in whom complete excision of all disease is feasible. For clinically localized melanoma (clinical stages 0-II), wide excision and, when appropriate, sentinel lymph node biopsy are well established. The management of stage III melanoma is more contentious. Resection remains the first choice of therapy for patients with oligometastatic melanoma in accessible locations, but careful consideration of preoperative use of highly active drugs is appropriate. Decisions regarding surgical management of stage IV melanoma should routinely be made in the context of a multidisciplinary team approach.
Keywords: Lymphadenectomy; Melanoma; Metastasectomy; Sentinel node biopsy; Surgery.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Surgical treatment of malignant melanoma.Surg Clin North Am. 2003 Feb;83(1):109-56. doi: 10.1016/S0039-6109(02)00205-0. Surg Clin North Am. 2003. PMID: 12691453 Review.
-
Sentinel-node biopsy or nodal observation in melanoma.N Engl J Med. 2006 Sep 28;355(13):1307-17. doi: 10.1056/NEJMoa060992. N Engl J Med. 2006. PMID: 17005948 Clinical Trial.
-
Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.Clin Dermatol. 2009 Nov-Dec;27(6):594-6. doi: 10.1016/j.clindermatol.2008.09.017. Clin Dermatol. 2009. PMID: 19880046 Review.
-
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E. Ann Plast Surg. 2003. PMID: 12783009
-
Surgical management of melanoma.Hematol Oncol Clin North Am. 2009 Jun;23(3):565-81, x. doi: 10.1016/j.hoc.2009.03.002. Hematol Oncol Clin North Am. 2009. PMID: 19464603 Review.
Cited by
-
Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.J Surg Oncol. 2016 Jan;113(1):98-102. doi: 10.1002/jso.24088. Epub 2015 Dec 10. J Surg Oncol. 2016. PMID: 26661407 Free PMC article.
-
Unlocking melanoma Suppression: Insights from Plasma-Induced potent miRNAs through PI3K-AKT-ZEB1 axis.J Adv Res. 2025 Feb;68:147-161. doi: 10.1016/j.jare.2024.02.022. Epub 2024 Mar 4. J Adv Res. 2025. PMID: 38447612 Free PMC article.
-
Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications.Ther Adv Med Oncol. 2015 May;7(3):181-91. doi: 10.1177/1758834015572284. Ther Adv Med Oncol. 2015. PMID: 26673806 Free PMC article. Review.
-
XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.Tumour Biol. 2016 Mar;37(3):3163-71. doi: 10.1007/s13277-015-4123-6. Epub 2015 Oct 2. Tumour Biol. 2016. PMID: 26427666
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical